Author: digi

Documenting OOS Investigations in Audit-Ready Format

In the pharmaceutical industry, documenting out-of-specification (OOS) results in a clear, compliant, and audit-ready format is crucial to maintaining regulatory compliance and product quality. Whether you’re preparing for a routine USFDA inspection or a surprise internal audit, the structure and clarity of your OOS investigation report can significantly influence your company’s compliance standing. 📝 Understanding…

Deviation and OOS Handling in Stability Testing, Pharmaceutical Quality and Practices

Designing a Study to Evaluate Shelf Life Across Storage Conditions

Evaluating a drug product’s shelf life requires more than simply placing it in a stability chamber. It demands a well-structured study design that considers storage conditions, regulatory zones, packaging, and testing intervals. This tutorial offers a step-by-step guide to designing shelf life evaluation studies tailored for pharmaceutical professionals aiming for global regulatory compliance. 📦 Why…

Factors Affecting Drug Shelf Life (Storage Conditions, Container, Light, etc.), Shelf Life and Expiry

Checklist for Regional Regulatory Submission of Stability Data

Preparing a regulatory dossier that includes stability data is a cornerstone of pharmaceutical product approval. However, the format, documentation, and expectations for stability data vary significantly across agencies like the FDA, EMA, ASEAN, and TGA. This detailed checklist ensures your stability data package meets the expectations of each major region, based on ICH Q1A (R2)…

Regional Guidelines: FDA, EMA, ASEAN, TGA, Regulatory Guidelines

Regulatory Guidance on Deviation Reporting in Stability Testing

In pharmaceutical stability testing, deviations—planned or unplanned—can significantly affect product quality and regulatory compliance. Regulatory authorities such as USFDA, EMA, and CDSCO closely examine how deviations are reported, assessed, and linked to corrective actions. A robust deviation reporting process is not only a GMP requirement but also a key quality system indicator during inspections. 📝…

Handling Deviations and CAPA in Stability Reports, Protocols and Reports

TGA Photostability Requirements Explained Step-by-Step

Australia’s Therapeutic Goods Administration (TGA) enforces rigorous stability testing requirements, including photostability, for pharmaceutical product registration. While the TGA references ICH Q1B, it has some region-specific expectations, especially for documentation and packaging evaluations. This step-by-step guide will walk you through TGA-compliant photostability studies to avoid regulatory delays or deficiencies. 💡 Step 1: Understand the Basis…

Regional Guidelines: FDA, EMA, ASEAN, TGA, Regulatory Guidelines

SOP for Applying ICH Q1A(R2) for Stability Testing of Drug-Device Combination Products

SOP for Applying ICH Q1A(R2) for Stability Testing of Drug-Device Combination Products Procedure for Stability Testing of Drug-Device Combination Products Following ICH Q1A(R2) Guidelines 1) Purpose The purpose of this SOP is to define the procedures for conducting stability testing on drug-device combination products in accordance with the International Council for Harmonisation (ICH) Q1A(R2) guidelines….

Stability Studies SOP

Calibration Checklist for GMP-Compliant Stability Chambers

Stability chambers are critical equipment in pharmaceutical manufacturing, used to store drug products under controlled temperature and humidity conditions. Ensuring they are properly calibrated and compliant with GMP (Good Manufacturing Practice) guidelines is vital for product integrity and regulatory adherence. This article provides a detailed calibration checklist for stability chambers, designed for pharma QA, validation,…

Equipment and Calibration, Stability Chamber Calibration and SOPs

Training Programs for Deviation and OOS Awareness in Pharma

In pharmaceutical quality systems, training programs for deviation and Out-of-Specification (OOS) awareness are essential to ensure consistent compliance, reduce recurring issues, and improve audit readiness. Regulatory authorities such as the USFDA and EMA expect documented evidence that employees understand and follow procedures for identifying, documenting, and resolving quality incidents. This article provides a comprehensive tutorial…

Deviation and OOS Handling in Stability Testing, Pharmaceutical Quality and Practices

Packaging Selection Tips to Prolong Drug Shelf Life

Pharmaceutical packaging is more than a protective shell—it plays a critical role in maintaining product stability and extending shelf life. Selecting the optimal packaging material and configuration can mitigate degradation risks from light, moisture, temperature, and oxygen exposure. This tutorial explores essential tips and considerations for packaging selection that pharma professionals should apply during product…

Factors Affecting Drug Shelf Life (Storage Conditions, Container, Light, etc.), Shelf Life and Expiry

Best Practices for CAPA Documentation in GMP Stability Protocols

Corrective and Preventive Actions (CAPA) are fundamental to Good Manufacturing Practices (GMP) and pharmaceutical quality systems. In the context of stability testing, any deviation—whether due to temperature excursions, out-of-specification (OOS) results, or documentation gaps—must be addressed through a compliant and traceable CAPA system. This article outlines best practices for documenting CAPA in stability protocols to…

Handling Deviations and CAPA in Stability Reports, Protocols and Reports